Search

Your search keyword '"Emi Noguchi"' showing total 1 results
Start Over Author "Emi Noguchi" Database MEDLINE
1 results on '"Emi Noguchi"'

1. Critical Appraisal of Adjuvant Platinum-Based Chemotherapy for Basal Subtype Triple-Negative Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy.

Author

Shimoi T, Noguchi E, Sudo K, Chua YJ, and Yonemori K

Subjects
Antineoplastic Combined Chemotherapy Protocols adverse effects, Chemotherapy, Adjuvant, Female, Humans, Neoadjuvant Therapy, Platinum therapeutic use, Breast Neoplasms drug therapy, Triple Negative Breast Neoplasms drug therapy
Abstract

Competing Interests: Emi NoguchiSpeakers' Bureau: Sysmex, AstraZeneca, Pfizer, Eisai, Lilly Japan, Chugai Pharma, Novartis Kazuki SudoHonoraria: AstraZeneca, Pfizer Kan YonemoriHonoraria: Eisai, Pfizer, AstraZeneca, Novartis, Taiho Pharmaceutical, Lilly JapanConsulting or Advisory Role: Chugai Pharma, Ono Pharmaceutical, Novartis, EisaiResearch Funding: Ono PharmaceuticalNo other potential conflicts of interest were reported.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results